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Abstract 
Objective: To evaluate the changes in cerebral blood flow during awake off-pump coronary artery 
bypass grafting and compare with the changes during off-pump coronary artery bypass grafting under 
general anesthesia, using continuous monitoring of regional cerebral oxygen saturation. 
Methods: The study population comprised 3 groups of patients who had undergone off-pump coronary 
artery bypass grafting with thoracic epidural anesthesia, general anesthesia, or a combination of the 
two. Regional brain oxygen saturation, determined with a near-infrared oxygen monitor, and mean 
arterial pressure during surgery were calculated and compared among the 3 groups. 
Results: Patients who had undergone awake off-pump coronary artery bypass grafting with thoracic 
epidural anesthesia had a significantly higher cerebrovascular impairment ratio, and the EuroSCORE 
was high. No significant differences were observed among the 3 groups in terms of the relationship 
between mean arterial pressure during surgery and regional brain oxygen saturation. It is suggested 
that there were no differences in cerebral blood flow and mean arterial pressure changes among the 3 
groups. 
Conclusions: Awake off-pump coronary artery bypass grafting is a safe surgical technique for patients 
with history of cerebral infarction or impaired cerebral blood flow. Awake off-pump coronary artery 
bypass grafting is a less invasive procedure that allows efficient management of intraoperative 
cerebral blood flow, and can be equally effective as a percutaneous coronary intervention. 
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Cerebral infarction is one of the serious complications that develop after coronary-bypass graft 
surgery (CABG). Off-pump coronary artery bypass grafting (OPCAB) is associated with fewer 
post-surgical cerebral infarctions than conventional CABG.
1-4
 This difference is likely because 
conventional CABG results in thrombi, air embolism, or intraoperative decrease in cerebral blood flow 
due to cardiopulmonary bypass. The incidence of postoperative cerebral infarction was 0.8-2.4% in 
OPCAB patients.
1-4
 Age and cerebrovascular disease have been associated with the increased risk for 
postoperative cerebral infarction.
3
 Our aim is to further reduce such incidences of postoperative 
cerebral infarction. 
Awake off-pump coronary artery bypass grafting (AOCAB) is a novel intraoperative or 
perioperative management technique introduced by Karagoz, et al. in 2000.
5
 We have also performed 
AOCAB under thoracic epidural anesthesia (TEA) in such high-risk patients with a history of cerebral 
infarction or impaired cerebral blood flow or severe pulmonary dysfunction since 2003.
6
 In AOCAB, 
general anesthesia or tracheal intubation are unnecessary because spontaneous breathing can be 
maintained by high TEA alone. Thus cerebrovascular data can be collected from conscious patients 
that enables effective monitoring.
7
 Hence, it has been anticipated that AOCAB can be performed in 
high-risk patients with a history of cerebral infarction, impaired cerebral blood flow detected during 
preoperative examination, or lower respiratory function. However, there has been no report on data of 
cerebral blood flow during AOCAB with comparison between AOCAB and OPCAB. 
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In the present study, we evaluated the changes in cerebral blood flow during AOCAB in 
comparison with the changes during OPCAB using continuous monitoring of the regional cerebral 
oxygen saturation (rSO2). 
 
Patients and Methods 
This study was approved by the Kanazawa University Hospital Research Ethics Committee, and 
informed consent was obtained from all patients. Twenty-one patients were enrolled in this 
prospective, nonrandomized study. The patients were divided into the following 3 groups: 7 patients 
who underwent AOCAB under epidural anesthesia alone (Group A), 7 patients who underwent 
OPCAB with a combination of general and epidural anesthesia (Group B), and 7 patients who 
underwent OPCAB under general anesthesia alone (Group C). Group A is a high-risk group, which 
comprised of patients who had history of cerebral infarction or impaired cerebral blood flow 
determined during preoperative examination. All patients underwent a color Doppler ultrasound study 
of the carotid arteries prior to surgery. If the patient had a history of carotid stenosis of 50% or more, 
they were divided into Group A. The patients of Group B and Group C do not have a history of 
cerebral infarction or impaired cerebral blood flow determined during preoperative examination. The 
patients of Group A and Group B did not receive preoperative anticoagulants and antiplatelets therapy 






On the day before the surgery, a thoracic epidural catheter was inserted at the T1-2 or T2-3 level 
in Group A and B patients by anesthesiologists in the operating room. We performed peridurography 
to confirm that the catheter was inserted in the epidural space. Continuous infusion of a mixture of 2% 
lidocaine (40 ml) and fentanyl (250 g) was initiated in the operating room on the day of surgery. For 
Group A patients, we began the AOCAB procedure after they had paralysis of the intercostal muscles, 
and after confirming the loss of cold/pain sensation in the appropriate areas and abdominal breathing. 
Group B patients were administered 1–1.5% sevoflurane and continuously infused with a mixture of 
2% lidocaine (40 ml) and fentanyl (250 g) via the epidural catheter. An epidural catheter was not 
inserted in Group C patients because they had received anticoagulants; the patients inhaled 1.5–2% 
sevoflurane and received intravenous fentanyl during OPCAB. 
 
Evaluation of patients’ background 
Table 1 shows patients’ characteristics to compare the background of the patients. We used Euro 
SCORE (European System for Cardiac Operative Risk Evaluation) II for a predictive index of the 
operation risk of the patients. Euro SCORE II is a risk model which allows the calculation of the risk 
of death after a heart operation. The model asks for 17 items of information about the patient, the state 






Cerebral saturation monitoring measurement 
During surgery, we monitored cerebral blood flow with a near-infrared oxygen monitor 
(NIRO-300; Hamamatsu Photonics KK, Hamamatsu, Japan) and determined the rSO2. This device 
transcranially measures tissue oxygenation index by using a near-infrared spectrometer. This index is 
evaluated by the ratio of oxygenated hemoglobin to the total hemoglobin in the tissue and is expressed 
as a percentage. This value was measured every 5 seconds before inducing anesthesia and until the 
completion of the surgery by attaching a probe to the patient’s forehead. The mean tissue oxygenation 
was calculated and compared among the 3 groups at the following points: before anesthesia; after 
anesthesia; and at the time of anastomosis to the left anterior descending artery, left circumflex artery, 
or right coronary artery. 
 
Evaluation of serous S-100β 
S-100β is released into the cerebrospinal fluid upon damage to the cranial nerve system or into 
the blood stream upon disruption of blood-brain barrier; therefore, S-100β has been reported to be a 
possible indicator of cranial nerve impairment.
9
 We measured serous S-100β levels by enzyme-linked 
immunosorbent assay (ELISA) (YK150 Human S-100β ELISA kit, Fujinomiya, JAPAN) before 
surgery, in the ward immediately after surgery, and 1 and 3 days after surgery, and compared the 




Hemodynamic assessment  
We measured the heart rate (HR) and mean arterial pressure (MAP) during surgery by inserting a 
catheter into the radial artery, determined pulmonary artery pressure and the central venous pressure 
(CVP) by inserting a pulmonary artery catheter through the right internal jugular vein. HR and MAP, 
pulmonary artery pressure, CVP were also calculated and compared among the 3 groups before 
anesthesia; after anesthesia; and at the time of anastomosis to the left anterior descending artery, left 
circumflex artery, or right circumflex artery. Intravenous methoxamine hydrochloride was mainly 




Data are expressed as mean ± standard deviation. Statistical analysis was performed with the 
Statistical Package for the Social Sciences software (SPSS, Chicago, IL, USA). Multiple comparisons 




The patient characteristics and operative data are shown in Table 2. In Group A, the ratio of the 
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cerebrovascular impairment and Euro SCORE II were significantly high, therefore Group A is a 
significant high-risk group. No statistically significant differences were noted among the groups with 
mean age, gender, weight, body surface area, hypertention, diabetes, myocardial infarction, or ejection 
fraction. None of the patients developed a new cerebral infarction or died in the perioperative stage. 
No patient in Group A was converted to general anesthesia. Because patients became verbose, irritable, 
or their level of consciousness decreased when MAP decreased to 50mmHg or less, we administered 
vasopressor at real time and maintained normalized consciousness. There were no significant 
differences in terms of the amount of methoxamine hydrochloride used among 3 groups.  
In Table 3, HR, MAP, pulmonary artery pressure, CVP, and rSO2 before and after anesthesia and 
according to the anastomosis location are shown. Preanesthetic HR was significantly higher in Group 
C than in other groups, but there were no significant differences in any other parameters. There were 
no significant differences in hemodynamics during surgery among the 3 groups. 
The correlation between rSO2 and MAP among the 3 groups is shown in scattergrams (Figures 1, 2). 
At MAP 60 mmHg and above, rSO2 was approximately constant regardless of MAP and no significant 
relationship was observed between MAP and rSO2 during surgery in all 3 groups (Figure 1). Thus at 
MAP 60 mmHg and above, autoregulation was similarly maintained in all 3 groups (Figure 2). 
At MAP less than 60mmHg, rSO2 had an approximately direct proportional relation with MAP, and 
no significant differences in relationship were observed between MAP and rSO2 during surgery among 
all 3 groups. 
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Although serous levels of S-100β were evaluated, no significant differences among the groups were 
observed (Table 4). 
 
Discussion 
In the present study, it was possible to prove the relationship between MAP and cerebral blood flow 
during AOCAB by evaluating intra-operative cerebral blood flow using rSO2 as an index. In AOCAB, 
cerebral blood flow is maintained by autoregulation at MAP≥60mmHg. However, symptoms due to 
decreased level of cerebral blood flow were observed at MAP≤50mmHg. Comparing OPCAB with 
AOCAB, though patients of Group B and C had no history of impaired cerebral blood flow, cerebral 
blood flow was maintained by autoregulation at MAP≥60mmHg but autoregulation was lost at 
MAP<60mmHg, and as with AOCAB, the level of cerebral blood flow decreased as MAP decreased. 
When MAP decreased during AOCAB, considering also the necessity to maintain consciousness, by 
using a vasopressor we were able to successfully perform the surgery without converting to general 
anesthesia.  
  Cerebral autoregulation can maintain normal cerebral blood flow at an average pressure of 
60-150mmHg.
10
 Once out of that range, autoregulation does not function, and cerebral blood flow 
cannot be maintained. It has been suggested that an overly decreased level of cerebral blood flow can 
trigger cerebral infarction. According to our data, whether patients underwent surgery with epidural 
anesthesia, general anesthesia employing sevoflurane, which is said to increase cerebral blood flow 
11
, 
or a combination of the two, the level of cerebral blood flow decreased as MAP decreased. Even in 
OPCAB which is performed without using cardiopulmonary bypass, MAP remains under 50mmHg, 
causing the level of cerebral blood flow to remain low. This condition may be one of the reasons for 
incidences of cerebral infarction associated with OPCAB. Measuring cerebral blood flow using a 
near-infrared oxygen monitor is easy and quick. In AOCAB, by measuring cerebral blood flow and 
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being aware of the patient’s level of consciousness, impaired cerebral blood flow can be immediately 
detected and treated. AOCAB is a useful method for lowering incidences of cerebral infarction and 
maintaining patient QOL. It is also a promising ultra-minimally invasive method for high-risk patients 
with impaired cerebral blood flow.  
Recently, several major thoracic procedures performed in awake patients have been reported.
5-7
 In 
order to reduce the adverse effects of general anesthesia and the cost, TEA has been employed to 
perform such awake thoracic surgery procedures. AOCAB is a novel intraoperative or perioperative 
management technique. This surgical method opens the door to surgical treatment for high-risk 
patients with serious diseases in whom general anesthesia is difficult, as well as allowing patients who 
opt for early recovery to return to normal living shortly after surgery with markedly improved QOL. 
AOCAB has other advantages compared to OPCAB. We have reported that the hypercoagulable state 
at 5 days after the operation was suggested in the OPCAB group, but not in those in the AOCAB 
group.
12
 We also demonstrated 
13
 that AOCAB reduces incidences of postoperative atrial fibrillation 
due to its inhibition of sympathetic activity without inhibiting vagal activity which causes 
antiarrythmic effects. This study suggests that reduced incidences of postoperative atrial fibrillation in 
AOCAB are due to the effect of TEA. However, in the present study, the changes in the cerebral blood 
flow were almost equivalent among the 3 groups; suggesting that TEA had hardly any influence.  
Continuous monitoring of rSO2 is possible by attaching a probe to the patient’s forehead. 
Near-infrared spectrometry and bispectral index are non-invasive methods to evaluate cerebral blood 
flow.
14
 This method that we used is simple, non-invasive, and can be achieved at real-time; therefore, 
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rSO2 is measured during open heart surgery.
15,16
 In the present study, rSO2 changed quickly with mean 
blood pressure, especially when the heart was displaced. During anastomosis of the left circumflex 
artery, both the mean blood pressure and rSO2 decreased. However, since the rSO2 probe can only be 
attached to the forehead, the area that can be monitored is limited to that perfused by the anterior 
cerebral artery. Therefore, it is necessary to develop a probe that allows monitoring of other areas. 
S-100 protein is a neural specific protein that can bind calcium. The S-100 protein consists of 2 
subunits: α and β chains. The β-chain subunit is present in the glial cells or Schwann cells. S-100β can 
be a good indicator of cerebrovascular impairment because the blood level of S-100β increases after a 
cerebral event.
17,18
 However, in our study, no patients experienced cerebrovascular impairment after 
surgery, and most likely due to this result, there were no significant differences in the S-100β levels 
among the 3 groups.  
This trial had several limitations to compare AOCAB and OPCAB. First of all, the background of 
the three groups highly differ. All patients with impaired cerebral blood flow were enrolled in Group 
A. It is necessary to conduct a study of matching patients, however, this limitation is a result of our 
view that, when it is possible to apply epidural anesthesia, it is more effective to perform AOCAB for 
patients with impaired cerebral blood flow. Also, the size of the groups must be increased for a more 






We evaluated cerebral blood flow by using near-infrared oxygen monitor during AOCAB. Though 
Group A included extremely high-risk patients, there were no significant differences in cerebral blood 
flow compared to the other 2 groups. AOCAB was a safe surgical technique for the patients with a 
history of cerebral infarction or impaired cerebral blood flow. AOCAB is a less invasive operative 
procedure that allows efficient management of intraoperative cerebral blood flow and can be equally 
effective as percutaneous coronary intervention. 
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FIGURE 1. Relationship between rSO2 and MAP 60 mmHg and above, a) in Group A, b) in Group B, 
c) in Group C 









FIGURE 2. Relationship between rSO2 and MAP less than 60 mmHg, a) in Group A, b) in Group B, 
c) in Group C 




TABLE 1. Patient characteristics and operative data 
  Group A (n = 7) Group B (n = 7) Group C (n = 7) p Value 
Age (y) 66.4 ± 8.4 68.0 ± 13.7 63.0 ± 7.9 0.62 
Male 6 6 6 1 
Weight (kg) 57.5 ± 11.1 57.6 ± 7.8 55.9 ± 8.9 0.87 
Body surface area (m
2
) 1.58 ± 0.1 1.59 ± 0.1 1.53 ± 0.1 0.61 
Cerebral infarction or 
Cerebrovascular impairment 
7 0 0 <0.01 
Hypertension 3 4 3 0.82 
Diabetes 7 5 4 0.29 
Hyperlipidemia 1 4 1 0.26 
Myocardial infarction 3 2 3 0.81 
Ejection fraction (%) 61.0 ± 16 60.6 ± 14.6 50.3 ± 6.6 0.55 
Euro SCORE II (%) 1.33±0.49 0.83±0.41 0.63±0.10 <0.01 
 
TABLE 2. Operative data  
  Group A  Group B  Group C p Value 
Operation time (min)  195.5 ± 72.2 245 ± 55.3 232.1 ± 745.5 0.53 
Number of distal anastomosis 2.2 ± 1.1 2.8 ± 0.6 2.6 ± 0.7 0.33 
Methoxamine hydrochloride (mg) 2.8 ± 2.8 9.0 ± 7.1 4.0 ± 3.0 0.25 
Operation end - extubates time (min) 0 25.7±6.71 22.8±2.7 <0.01 
New cerebral infarction  0 0 0 1 




TABLE 3. Mean values of patient parameters pre- and post-anesthesia and at each anastomosis region 
    Group A Group B Group C p Value 
Heart rate (/min) 
Pre-anesthesia 65.7 ± 6.6 73.8 ± 1.5 80.2 ± 7.2 0.04 
Post-anesthesia 68.4 ± 3.9 58.7 ± 6.4 68.7 ± 14.4 0.30 
LAD 67.8 ± 5.1 63.5 ± 8.2 66.5 ± 10.5 0.53 
LCX 58.6 ± 4.9 66.4 ± 5.6 73.6 ± 14.4 0.17 
RCA 68.3 ± 8.9 72.2 ± 4.9 58.8 ± 5.0 0.11 
      
MAP (mmHg) 
Pre-anesthesia 82.7 ± 17 114 ± 14 80.7 ± 15 0.27 
Post-anesthesia 71.1 ± 15 69.4 ± 12.9 78.5 ± 16.9 0.50 
LAD 60.6 ± 7.2 61.6 ± 7.0 63.7 ± 6.0 0.58 
LCX 54.4 ± 2.1 60.2 ± 9.0 57.6 ± 4.9 0.26 
RCA 61.1 ± 12.4 61.5 ± 9.3 56.5 ± 4.6 0.51 
      
MPAP (mmHg) 
Pre-anesthesia 19.5 ± 4.4 18.6 ± 1.9 22.8 ± 9.2 0.43 
Post-anesthesia 19.7 ± 3.3 17.2 ± 3.1 23.7 ± 7.9 0.16 
LAD 21 ± 4.7 19.5 ± 3.6 20.5 ± 4.4 0.66 
LCX 16.2 ± 0.8 21.3 ± 4.3 21.5 ± 2.7 0.61 
RCA 22.9 ± 6.2 21.7 ± 4.2 17.3 ± 0.9 0.25 
      
CVP (mmHg) 
Pre-anesthesia 6 ± 2.9 5.4 ± 1.1 4.3 ± 3.4 0.46 
Post-anesthesia 8.4 ± 4.1 8.5 ± 0.8 8.7 ± 2.7 0.89 
LAD 7.7 ± 6.1 10.4 ± 3.7 6.9 ± 2.2 0.36 
LCX 9.9 ± 0.4 10.3 ± 3.4 13.1 ± 3.7 0.33 
RCA 8.2 ± 3.6 13.1 ± 3.2 11.5 ± 0.1 0.17 
      
rSO2 (%) 
Pre-anesthesia 63.2 ± 3.1 65.1 ± 4.1 61.6 ± 2.8 0.25 
Post-anesthesia 63.9 ± 4.3 64.2 ± 4.3 62.3 ± 4.7 0.34 
LAD 62.8 ± 6.4 63.5 ± 4.3 59.3 ± 5.0 0.40 
LCX 61.8 ± 0.4 62.1 ± 3.7 59.0 ± 4.0 0.37 
RCA 62.9 ± 2.6 63.0 ± 4.3 58.9 ± 2.6 0.34 
LAD: left anterior descending artery, LCX: left circumflex artery, MAP: mean arterial pressure, 




TABLE 4. Changes in the serous levels of S-100β (ng/ml) 
  Group A Group B Group C p Value 
Before surgery 0.15 ± 0.03 0.15± 0.05 0.14 ±0.02 0.73 
Immediately after surgery 1.13 ± 0.13 1.39 ± 0.13 1.40 ± 0.15 0.38 
1 day after the operation 0.65 ± 0.12 0.48 ± 0.14 0.51 ± 0.14 0.45 
3 days after the operation 0.22 ± 0.08 0.24 ± 0.05 0.23 ± 0.08  0.70 
 
 
